Curida attracts new investors

Published: 24 Sep 2018

The Norwegian pharmaceutical manufacturer Curida has attracted yet another strong private investor. Stokke Industri AS joins the Curida team along with Canica, Klaveness Marine and Investinor. Curida has now raised more than 100 million NOK from external investors.

– The investment and experience that Stokke Industri brings will further strenghten our financial and industrial platform, says Leif Rune Skymoen, CEO of Curida.

– We have established a strong team of investors. This will allow us to pursue some very exciting opportunities, says Curida Chairman Per S. Thoresen.

Curida was established in 2015, as a result of an employee and management buy-out of the former Takeda and Nycomed manufacturing site in Elverum, Norway. In December 2017, Canica and Klaveness Marine invested 25 MNOK each in Curida. Investinor, funded by the Norwegian government, invested 25 MNOK in January 2018. Curida can now add a fourth external investor to its list of owners.
Investment Director Stein Egil Valderhaug at Stokke Industri says that:

– Curida is a company that we strongly believe in, and we look forward to working with the management, the employees and the other owners to further develop the company.

—————————————————————————

About Stokke Industri AS
Stokke Industri AS is a Norwegian family office owned by Rune Stokke, Maria Loen and their children.
The company focuses on investments in industry, property and finance. The company seeks investments where the industrial knowledge and history can make a difference.
The company is built on more than 85 years of industry experience in several areas. Stokke AS with the famous collection of Children’s equipment is most known and was sold in 2014.

About Curida AS
Curida AS is a pharmaceutical CDMO with 90 employees. The company manufactures and exports liquid pharmaceuticals.
Curida is the result of a management and employee buyout of the former Nycomed and Takeda manufacturing site in Elverum, Norway. Curida was established in 2015, and builds on more than 40 years of experience from pharma manufacturing.
In January 2018, Curida acquired Ås produksjonslab, located south of Oslo, Norway.
Curida’s commercial office is located in Oslo Cancer Cluster Innovation Park.

Contact persons:
Stein Egil Valderhaug, Investment Director, Stokke Industri, mobile +47 916 19 134
Per S. Thoresen, Chairman, Curida, mobile +47 906 14 620
Leif Rune Skymoen, CEO, Curida, mobile +47 996 49 419